Literature DB >> 35038160

Deduction and exploration of the evolution and function of vertebrate GFPT family.

Si-Ang Wei1, Ran Xu1, Yu-Yao Ji1, Zhi-Wen Ding2, Yun-Zeng Zou3.   

Abstract

BACKGROUND: Glutamine-fructose-6-phosphate aminotransferase (GFPT) is a key factor in the hexosamine metabolism pathway. It regulates the downstream factor O-GlcNAc to change cell function and plays an important role in the metabolism and immune process of tissues and organs. However, the evolutionary relationship of GFPT family proteins in vertebrates has not been elucidated.
OBJECTIVE: To deduce and explore the evolution and function of vertebrate GFPT family.
METHODS: 18 GFPT sequences were obtained from Homo sapiens (H. sapiens), Trachypithecus francoisi (T. francoisi), Mus musculus (M. musculus), Rattus norvegicus (R. norvegicus), Gallus gallus (G. gallus), Zootoca vivipara (Z. vivipara), Xenopus tropicalis (X. tropicalis), Danio rerio (D. rerio), Rhincodon typus (R. typus), Plasmodium relictum from National Center for Biotechnology Information (NCBI). The physical and chemical characteristics and molecular evolution of GFPT family proteins and nucleic acid sequences were analyzed by ClustalX2, Gene Doc, MEGA-X, SMART, Datamonkey, R etc.
RESULTS: Based on the neighbor-joining (NJ) phylogenetic tree and evolution fingerprints, GFPT family members of vertebrates can be divided into two groups: the GFPT1 group and the GFPT2 group. Seven positive selection sites were identified by IFEL and integrated methods mixed effects model of evolution (MEME) and fixed effects likelihood (REL). Finally, we predicted 28 phosphorylation sites and 18 ubiquitousness sites in the human GFPT1 sequence, 10 phosphorylation sites, and five ubiquitousness sites in GFPT2. Gene ontology (GO) analyzes the protein molecules and KEGG signaling pathways of vertebrates interacting with GFPT family proteins.
CONCLUSIONS: Our work confirmed that higher animals GFPT family may have differentiated GFPT1 and GFPT2, which meets their own functional needs. This knowledge answers the question what the origin and evolution of GFPT family in vertebrates and provided the basis for disease treatment and function research of GFPT protein.
© 2022. The Author(s) under exclusive licence to The Genetics Society of Korea.

Entities:  

Keywords:  Evolution fingerprints; GFPT; GO analyzes; Phosphorylation sites; Phylogenetic tree; Positive selection; Properties

Mesh:

Year:  2022        PMID: 35038160     DOI: 10.1007/s13258-021-01188-8

Source DB:  PubMed          Journal:  Genes Genomics        ISSN: 1976-9571            Impact factor:   1.839


  41 in total

1.  Datamonkey 2010: a suite of phylogenetic analysis tools for evolutionary biology.

Authors:  Wayne Delport; Art F Y Poon; Simon D W Frost; Sergei L Kosakovsky Pond
Journal:  Bioinformatics       Date:  2010-07-29       Impact factor: 6.937

Review 2.  Origin and early evolution of the vertebrates: new insights from advances in molecular biology, anatomy, and palaeontology.

Authors:  N D Holland; J Chen
Journal:  Bioessays       Date:  2001-02       Impact factor: 4.345

3.  Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy.

Authors:  Stéphanie Bauché; Geoffroy Vellieux; Damien Sternberg; Marie-Joséphine Fontenille; Elodie De Bruyckere; Claire-Sophie Davoine; Guy Brochier; Julien Messéant; Lucie Wolf; Michel Fardeau; Emmanuelle Lacène; Norma Romero; Jeanine Koenig; Emmanuel Fournier; Daniel Hantaï; Nathalie Streichenberger; Veronique Manel; Arnaud Lacour; Aleksandra Nadaj-Pakleza; Sylvie Sukno; Françoise Bouhour; Pascal Laforêt; Bertrand Fontaine; Laure Strochlic; Bruno Eymard; Frédéric Chevessier; Tanya Stojkovic; Sophie Nicole
Journal:  J Neurol       Date:  2017-07-15       Impact factor: 4.849

4.  A Not-So-Long Introduction to Computational Molecular Evolution.

Authors:  Stéphane Aris-Brosou; Nicolas Rodrigue
Journal:  Methods Mol Biol       Date:  2019

5.  The Effect of Strong Purifying Selection on Genetic Diversity.

Authors:  Ivana Cvijović; Benjamin H Good; Michael M Desai
Journal:  Genetics       Date:  2018-05-29       Impact factor: 4.562

6.  Leukoencephalopathy due to variants in GFPT1-associated congenital myasthenic syndrome.

Authors:  Guy Helman; Suvasini Sharma; Joanna Crawford; Bijoy Patra; Puneet Jain; Stephen J Bent; J Andoni Urtizberea; Ravindra K Saran; Ryan J Taft; Marjo S van der Knaap; Cas Simons
Journal:  Neurology       Date:  2019-01-11       Impact factor: 9.910

7.  Mannose Phosphate Isomerase and Mannose Regulate Hepatic Stellate Cell Activation and Fibrosis in Zebrafish and Humans.

Authors:  Charles DeRossi; Kathryn Bambino; Joshua Morrison; Isabel Sakarin; Carlos Villacorta-Martin; Changwen Zhang; Jillian L Ellis; M Isabel Fiel; Maria Ybanez; Youngmin A Lee; Kuan-Lin Huang; Chunyue Yin; Takuya F Sakaguchi; Scott L Friedman; Augusto Villanueva; Jaime Chu
Journal:  Hepatology       Date:  2019-05-24       Impact factor: 17.425

8.  Congenital myasthenic syndromes.

Authors:  Josef Finsterer
Journal:  Orphanet J Rare Dis       Date:  2019-02-26       Impact factor: 4.123

9.  Natural selection contributed to immunological differences between hunter-gatherers and agriculturalists.

Authors:  George H Perry; Luis B Barreiro; Genelle F Harrison; Joaquin Sanz; Jonathan Boulais; Michael J Mina; Jean-Christophe Grenier; Yumei Leng; Anne Dumaine; Vania Yotova; Christina M Bergey; Samuel L Nsobya; Stephen J Elledge; Erwin Schurr; Lluis Quintana-Murci
Journal:  Nat Ecol Evol       Date:  2019-07-29       Impact factor: 15.460

10.  AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.

Authors:  Roselle Gélinas; Florence Mailleux; Justine Dontaine; Laurent Bultot; Bénédicte Demeulder; Audrey Ginion; Evangelos P Daskalopoulos; Hrag Esfahani; Emilie Dubois-Deruy; Benjamin Lauzier; Chantal Gauthier; Aaron K Olson; Bertrand Bouchard; Christine Des Rosiers; Benoit Viollet; Kei Sakamoto; Jean-Luc Balligand; Jean-Louis Vanoverschelde; Christophe Beauloye; Sandrine Horman; Luc Bertrand
Journal:  Nat Commun       Date:  2018-01-25       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.